Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Creo Medical (GB:CREO) has launched an replace.
Creo Medical Group plc has amended its collaboration settlement with Intuitive Surgical Inc. to extend the variety...
Warwick, Warwickshire, United KingdomLeo Most cancers Care, in collaboration with DCA Design Worldwide, has pioneered an modern method to radiotherapy as that is...
